Aspect Magnet Technologies Announces Scientific Advisory Board Members
August 17, 2010
Netanya, Israel - Aspect Magnet Technologies Ltd. announced today that it has formed a scientific advisory board (https://aspect-mr.com/page.asp?page_id=19) to advise and help guide the company as it continues to develop a new generation (https://www.aspect-mr.com/page.asp?page_id=22) of compact, affordable, easy-to-use magnetic resonance imaging (MRI (https://aspect-mr.com/page.asp?page_id=42)) systems using its proprietary permanent magnet technology. “The willingness of this distinguished [...]
BAC and Octapharma Extend Collaboration for G-CSF Custom Ligand for Commercial Scale Manufacture
August 17, 2010
Naarden, The Netherlands – BAC BV, the leading provider of antibody-based affinity purification technology, today announced that it has entered into a licence agreement with Octapharma ( Lachen , Switzerland ), an independent, global provider of human proteins for life-threatening diseases. Under the terms of the license, Octapharma can use BAC’s G-CSF CaptureSelect® custom affinity [...]
U.S. FDA Expands DDDPlus™Software Licenses
August 17, 2010
LANCASTER, Calif. - Simulations Plus, Inc.(NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. Food and Drug Administration to expand the number of licenses for the Company’s DDDPlus™ simulation software. John DiBella, director of marketing and sales for Simulations Plus, [...]
August 17, 2010
St. Louis, MO and Copenhagen, Denmark - SAFC®, a member of the Sigma-Aldrich® Group (NASDAQ: SIAL), and Novozymes Biopharma DK A/S today announced a 10-year extension of their joint agreement under which SAFC retains exclusive marketing and distribution rights for Novozymes Biopharma’s LONG®R³IGF-I (LONG®R3) growth factor used for industrial cell culture applications. The highly potent [...]
Life Technologies Announces Agreement to Acquire Ion Torrent
August 17, 2010
Ion Torrent's First to Market PostLight(TM) Sequencing Technology to Expand Life Technologies' Leadership Position in Sequencing - Complements Existing Sequencing Solutions Portfolio CARLSBAD, Calif. & GUILFORD, Conn. - Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced a definitive agreement to acquire Ion Torrent for $375 million in cash and [...]
August 17, 2010
HOUSTON ? SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today that it has acquired the Illumina HiSeq 2000 Next Generation Sequencing System. Addition of the HiSeq 2000 platform enables SeqWright to perform the largest and most complex sequencing studies at the lowest possible cost to its customers. The ability [...]
August 17, 2010
Torrance, CA - Rapiscan Systems, a leader in advanced security screening solutions, today announced that it has been awarded a $1.6 million contract to provide a Eagle transmission X-ray cargo and vehicle inspection systems to a Eastern European customs agency. OSI Systems' CEO (Rapiscan's parent company), Deepak Chopra, stated, "This most recent order builds on [...]
UW Scientists Use 3D Cell Culture to Model Breast Cancer in BellBrook’s Microconduit Array Plates
August 17, 2010
Madison, WI - 3D cell culture models replicate in vivo tissue biology more accurately than conventional 2D monoculture, however their use in high throughput screening applications has been limited because of the difficulties in using matrix components like collagen in multiwell plates. In addition, 3D models often rely on primary cells, which are usually not [...]
Veeco Announces Sale of Metrology Business to Bruker Corporation
August 16, 2010
Company to Focus on Process Equipment for the LED, Solar and Data Storage Markets PLAINVIEW, N.Y. - Veeco Instruments Inc. (Nasdaq: VECO) today announced that it has agreed to sell its Metrology business to Bruker Corporation (Nasdaq: BRKR), a leading provider of high-performance scientific instruments and solutions for molecular and materials research, for $229 million [...]
ISCT joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership
August 16, 2010
Vancouver, Canada - Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development. The ISCT Industry Task Force (ITF), comprising [...]

